These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8653988)

  • 1. Response to Monro and Mehta proposal for use of single-dose toxicology studies to support single-dose studies of new drugs in humans.
    Choudary J; Contrera JF; DeFelice A; DeGeorge JJ; Farrelly JG; Fitzgerald G; Goheer MA; Jacobs A; Jordan A; Meyers L; Osterberg R; Resnick C; Sun CJ; Temple RJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):265-7. PubMed ID: 8653988
    [No Abstract]   [Full Text] [Related]  

  • 2. Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?
    Monro A; Mehta D
    Clin Pharmacol Ther; 1996 Mar; 59(3):258-64. PubMed ID: 8653987
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug safety and the role of clinical pharmacology in the safe use of therapeutics.
    Honig PK
    Clin Pharmacol Ther; 2009 Mar; 85(3):225-8. PubMed ID: 19223873
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety considerations in development of new animal drugs.
    Fogleman RW
    J Am Vet Med Assoc; 1972 Dec; 161(11):1381-4. PubMed ID: 4638516
    [No Abstract]   [Full Text] [Related]  

  • 6. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 7. Single dose toxicity and repeated dose toxicity studies: introductory remarks.
    Kurokawa Y; Matsuzawa T
    J Toxicol Sci; 1996 Dec; 21(5):413-6. PubMed ID: 9035047
    [No Abstract]   [Full Text] [Related]  

  • 8. Overdosage and-or poisoning--the information gap.
    Ellenhorn MJ
    J Clin Pharmacol; 1973; 13(5):181-9. PubMed ID: 4488653
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan; 71(1):34-9. PubMed ID: 16491527
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs and drug products from 1995.
    Gage TW
    Tex Dent J; 1996 Oct; 113(10):15-7, 19-22. PubMed ID: 9518826
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
    Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
    Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food and Drug Administration's Safe Use Initiative collaborating to reduce preventable harm from medications.
    U S Food And Drug Administration
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):76-93. PubMed ID: 20345207
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarkers on a roll.
    Nat Biotechnol; 2010 May; 28(5):431. PubMed ID: 20458308
    [No Abstract]   [Full Text] [Related]  

  • 14. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(105):37988-98. PubMed ID: 12049094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approvals. New drugs, new uses.
    Rodman MJ
    RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204
    [No Abstract]   [Full Text] [Related]  

  • 17. [The current requirements for the preclinical study of the safety of new drugs].
    Arzamastsev EV; Liubimov BI
    Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems relating to investigational drugs.
    Kelsey O
    Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715
    [No Abstract]   [Full Text] [Related]  

  • 19. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
    Jacobs A
    Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of a children's drug table.
    Shirkey HC
    Hosp Formul; 1979 Mar; 14(3):319-20, 325-6, 330. PubMed ID: 10316796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.